Pioglitazone hydrochloride: chemopreventive potential and development of site-specific drug delivery systems

References

• Brockman JA, Gupta RA, Dubois RN. (1998). Activation of PPAR [gamma] leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology 115:1049–55
   PubMed Web of Science ®Google Scholar
• Cao G, Sofic E, Prior RL. (1997). Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med 22:749–60
   PubMed Web of Science ®Google Scholar
• Dani V, Goel A, Vaiphei K, et al. (2007). Chemopreventive potential of zinc in experimentally induced colon carcinogenesis. Toxicol Lett 171:10–18
   PubMed Web of Science ®Google Scholar
• Ellman GL. (1959). Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–7
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–917
   PubMed Web of Science ®Google Scholar
• Friend DR. (2005). New oral delivery systems for treatment of inflammatory bowel disease. Adv Drug Deliv Rev 57:247–65
   PubMed Web of Science ®Google Scholar
• Ghimire M, Hodges LA, Band J, et al. (2010). In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets. J Control Release 147:70–5
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. (2000). Global cancer statistics. CA Cancer J Clin 61:69–90
   Google Scholar
• Kato M, Kusumi T, Tsuchida S, et al. (2004). Induction of differentiation and peroxisome proliferator-activated receptor gamma expression in colon cancer cell lines by troglitazone. J Cancer Res Clin Oncol 130:73–9
   PubMed Web of Science ®Google Scholar
• Kono Y. (1978). Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186:189–95
   PubMed Web of Science ®Google Scholar
• Kota BP, Huang TH, Roufogalis BD. (2005). An overview on biological mechanisms of PPARs. Pharmacol Res 51:85–94
   PubMed Web of Science ®Google Scholar
• Krishnan K, Ruffin MT. (2000). Chemoprevention for colorectal cancer. Crit Rev Oncol Hematol 33:199–219
   PubMed Web of Science ®Google Scholar
• Kyle ME, Miccadei S, Nakae D, et al. (1987). Superoxide dismutase and catalase protect cultured hepatocytes from the cytotoxicity of acetaminophen. Biochem Biophys Res Commun 149:889–96
   PubMed Web of Science ®Google Scholar
• Laxmi G, Mukhopadhyay S, Durgapal S. (2010). Simultaneous estimation of metformin and pioglitazone by ultraviolet spectrophotometry. Indian J Pharm Sci 72:508–10
   PubMed Web of Science ®Google Scholar
• Lefebvre AM, Chen I, Desreumaux P, et al. (1998). Activation of the peroxisome proliferator-activated receptor promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med 4:1053–7
   PubMed Web of Science ®Google Scholar
• Luck H. (1954). Quantitative determination of catalase activity of biological material]. Enzymologia 17:31–40
   PubMedGoogle Scholar
• Mates JM, Sanchez-Jimenez F. (1999). Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci 4:D339–45
   PubMedGoogle Scholar
• Nakagami K, Uchida T, Ohwada S, et al. (1999). Increased choline kinase activity in 1,2-dimethylhydrazine-induced rat colon cancer. Jpn J Cancer Res 90:1212–17
   PubMedGoogle Scholar
• Pillai MG, Thampi BS, Menon VP, et al. (1999). Influence of dietary fiber from coconut kernel (Cocos nucifera) on the 1, 2-dimethylhydrazine-induced lipid peroxidation in rats. J Nutr Biochem 10:555–60
   PubMed Web of Science ®Google Scholar
• Sarraf P, Mueller E, Jones D, et al. (1998). Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nat Med 4:1046–52
   PubMed Web of Science ®Google Scholar
• Schmelz EM, Sullards MC, Dillehay DL, et al. (2000). Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1, 2-dimethylhydrazine-treated CF1 mice. J Nutr 130:522–7
   PubMed Web of Science ®Google Scholar
• Shen D, Deng C, Zhang M. (2007). Peroxisome proliferator-activated receptor agonists inhibit the proliferation and invasion of human colon cancer cells. Postgrad Med J 83:414–19
   PubMed Web of Science ®Google Scholar
• Shimada T, Kojima K, Yoshiura K, et al. (2002). Characteristics of the peroxisome proliferator activated receptor (PPAR) ligand induced apoptosis in colon cancer cells. Gut 50:658–64
   PubMed Web of Science ®Google Scholar
• Sinha VR, Mittal BR, Bhutani KK, et al. (2004). Colonic drug delivery of 5-fluorouracil: an in vitro evaluation. Int J Pharm 269:101–8
   PubMed Web of Science ®Google Scholar
• Takahashi H, Hosono K, Uchiyama T, et al. (2010). PPAR ligand as a promising candidate for colorectal cancer chemoprevention: a pilot study. PPAR Res 2010:pii257835
   Google Scholar
• Tan MH, Johns D, Strand J, et al. (2004). Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes. Diabetic Med 21:859–66
   PubMed Web of Science ®Google Scholar
• Tanaka T, Kawabata K, Kakumoto M, et al. (1998). Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes. Cancer Res 58:2550–6
   PubMed Web of Science ®Google Scholar
• Velasco M, Ford JL, Rowe P, et al. (1999). Influence of drug: hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J Control Release 57:75–85
   PubMed Web of Science ®Google Scholar
• Wills ED. (1966). Mechanisms of lipid peroxide formation in animal tissues. Biochem J 99:667–76
   PubMed Web of Science ®Google Scholar